<DOC>
	<DOCNO>NCT00829712</DOCNO>
	<brief_summary>The objective randomized , single-dose , two-way evaluation compare bioequivalence test dexmethylphenidate hydrochloride formulation equivalent oral dose commercially available dexmethylphenidate hydrochloride test population 24 adult subject fast condition .</brief_summary>
	<brief_title>Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria 1 . Sex : Male Female ; similar proportion prefer . 2 . Age : At least 18 year . 3 . Weight : BMI ( Body Mass Index ) less equal 30 . 4 . Qualifying subject must good health physical condition determine medical history , complete physical examination , laboratory test , obtain within four ( 4 ) week prior study start . The subject may history significant past illness expect affect investigation . The normal status subject confirm follow procedure : Laboratory Tests : Hemoglobin , hematocrit , RBC , WBC , differential count , serum electrolyte ( Na , K , Cl ) , fast blood glucose , BUN , bilirubin , creatinine , AST , ALT , LD , alkaline phosphatase urinalysis . HIV , Hepatitis B , Hepatitis C , breath alcohol test , drug abuse test do screening purpose . Urine drug abuse test breath alcohol test repeat checkin . Female subject serum pregnancy test do screen urine pregnancy test prior study period checkin . Laboratory value great Â±20 % normal range qualify unless specifically accept ( comment ) Principal Investigator . Results HIV , Hepatitis B , Hepatitis C , drug abuse must negative nonreactive subject qualify study . Electrocardiogram : A 12lead electrocardiogram ( ECG ) obtain subject . The original tracing , plus interpretation , include case report form packet . 5 . Subjects must read sign Consent Form . Exclusion Criteria 1 . Subjects comply inclusion criterion must exclude study . 2 . In addition , one condition list exclude subject study : History treatment alcoholism , substance abuse , drug abuse within past 24 month . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . History GERD ( gastroesophageal reflux disease ) , stricture esophagus , achalasia , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease . History upper gastrointestinal disorder dysphagia , esophagitis , gastritis , ulcer . History treatment asthma within past five ( 5 ) year . History mark treatable anxiety , tension , agitation . History glaucoma History motor tic Family history diagnosis tourettes syndrome History treatment monoamine oxidase inhibitor History seizures Inability sit upright period least 30 minute Females pregnant lactate History hypersensitivity dexmethylphenidate hydrochloride , methylphenidate central nervous system stimulant 3 . Conditions upon screen might contraindicate require caution use administration dexmethylphenidate hydrochloride , include : Sitting systolic blood pressure 90 mm Hg , diastolic pressure 50 mm Hg . Heart rate le 50 beat per minute 5minute rest seat position . 4 . Inability read and/or sign consent form . 5 . Treatment investigational drug four ( 4 ) week prior initial dose study . 6 . Subjects donate blood within four ( 4 ) week prior initial dose study . 7 . Subjects smoke use tobacco product currently use nicotine product ( patch , gum , etc. ) . Three ( 3 ) month abstinence require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>